Patents Assigned to ENSOL BIOSCIENCES INC.
  • Peptide that supresses binding of beta-amyloid and rage
    Patent number: 10544190
    Abstract: The present invention provides a peptide consisting of the amino acid sequence of SEQ ID NO:1 or the amino acid sequence of SEQ ID NO:2, or a pharmaceutically acceptable salt thereof and a use thereof. The present invention can inhibit the entry of beta-amyloid into the brain. In addition, the present invention can be applied more easily with respect to the suppression of the intracerebral action of beta-amyloid and thus is advantageous in having excellent applicability.
    Type: Grant
    Filed: March 24, 2017
    Date of Patent: January 28, 2020
    Assignee: ENSOL BIOSCIENCES INC.
    Inventors: Hae Jin Kim, Eun Joung Moon, Duk Soon Hwang
  • Anti-cancer peptide and use thereof
    Patent number: 10189875
    Abstract: Provided are a peptide consisting of the amino acid sequence of SEQ ID NO:1 or a pharmaceutically acceptable salt thereof, and the use thereof. Cancer can be effectively prevented or treated by application of the peptide.
    Type: Grant
    Filed: July 22, 2016
    Date of Patent: January 29, 2019
    Assignee: ENSOL BIOSCIENCES INC.
    Inventors: Hae Jin Kim, Duk Soon Hwang, Eun Joung Moon
  • Anti-cancer peptide and use thereof
    Patent number: 10167316
    Abstract: Provided are a peptide consisting of the amino acid sequence of SEQ ID NO:1 or a pharmaceutically acceptable salt thereof, and the use thereof. Cancer can be effectively prevented or treated by application of the peptide.
    Type: Grant
    Filed: July 22, 2016
    Date of Patent: January 1, 2019
    Assignee: ENSOL BIOSCIENCES INC.
    Inventors: Hae JIn Kim, Duk Soon Hwang, Eun Joung Moon